| 2026-08-21 | Proxy | Definitive proxy statement |
| 2026-08-07 | 8-K | Form 8-K, Item 5.02 |
| 2026-07-30 | Press release | Neogen Reports Fourth Quarter and Full Fiscal Year 2026 Financial Results |
| 2026-07-30 | Deck | Q4 FY2026 Earnings Call |
| 2026-07-30 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-30 | 10-K | Annual report on Form 10-K, FY26 |
| Transcript | Q4 FY26 earnings call transcript |
| 2026-07-20 | Press release | Neogen to Release Fourth-Quarter Fiscal Year 2026 Financial Results on |
| 2026-06-18 | Press release | Neogen® Committed to Helping Ranchers, Livestock Producers, and Horse Owners Fight Against New World Screwworm |
| 2026-04-23 | Press release | Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification |
| 2026-04-20 | 8-K | Form 8-K, Item 7.01 |
| 2026-04-09 | Press release | Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on |
| 2026-04-09 | Deck | Presentation of Q3 2026 |
| 2026-04-09 | Press release | Press Release of Q3 2026 |
| 2026-04-09 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-09 | 10-Q | Form 10-Q for the quarter ended Feb 28 |
| 2026-04-08 | Press release | Neogen® Corporation Announces Appointment of Jennifer Evans Stacey as Chief Legal & Compliance Officer and Board Secreta |
| 2026-03-30 | Press release | Download , Neogen to Release Third-Quarter Fiscal Year 2026 Financial Results on April 9, 2026, (opens i |
| 2026-03-30 | 8-K | Form 8-K, Item 5.02 |
| 2026-03-02 | Press release | Download , Neogen Announces Sale of Genomics Business to Zoetis |
| 2026-01-28 | Press release | Neogen Issues Voluntary Nationwide Recall of Neogen®Vet HYCOAT® Hyaluronate Sodium Sterile Solution |
| 2026-01-14 | Deck | Investor presentation · Jan 2026 |
| 2026-01-09 | Transcript | Q2 FY26 earnings call transcript |
| 2026-01-08 | Deck | Fiscal Year 2026 Second-Quarter Results |
| 2026-01-08 | Press release | Neogen Announces Second-Quarter Earnings Release Date · Q2 2026 |
| 2026-01-08 | Press release | Press Release of Q2 2026 Earnings |
| 2026-01-08 | 8-K | Form 8-K, Item 2.02 results |
| 2026-01-08 | 10-Q | Form 10-Q for the quarter ended Nov 30 |
| 2026-01-05 | Press release | Neogen® Announces Two Senior Leadership Appointments |
| 2025-12-17 | Press release | Neogen® To Participate in Upcoming Investor Conferences |
| 2025-10-30 | Press release | Neogen® Corporation Announces Appointment of Bryan Riggsbee as Chief Financial Officer |
| 2025-10-30 | 8-K | Form 8-K, Item 5.02 |
| 2025-10-28 | 8-K | Form 8-K/A, Item 5.02 |
| 2025-10-27 | 8-K | Form 8-K, Item 5.07 |
| 2025-10-27 | 8-K | Form 8-K/A, Item 5.07 |
| 2025-10-13 | Press release | Neogen® expands Colitag™’s water testing capabilities with launch of Neogen® MPNTray™ |
| 2025-10-09 | Deck | Fiscal Year 2026 First-Quarter Results |
| 2025-10-09 | Press release | Neogen Announces First-Quarter 2026 Results |
| 2025-10-09 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-09 | 10-Q | Form 10-Q for the quarter ended Aug 31 |